Clinical Research Directory
Browse clinical research sites, groups, and studies.
Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia
Sponsor: Jessa Hospital
Summary
This study aims to investigate the effectiveness of photobiomodulation therapy (PBM) in the prevention and management of chemotherapy-induced alopecia (CIA). Therefore, we hypothesize that PBMT can reduce the severity of CIA in gynecological and breast cancer patients, increasing the patient's QoL.
Official title: Evaluating the Feasibility and Efficacy of Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-induced Alopecia: a Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
72
Start Date
2022-02-28
Completion Date
2030-01
Last Updated
2023-09-29
Healthy Volunteers
No
Conditions
Interventions
Theradome® LH80 pro
The Theradome LH80 pro is a wearable laser helmet device, which uses red laser light to stop hair loss, thicken existing hair and stimulate the growth of new hair.
Scalp cooling
Scalp cooling is a standard treatment that is applied to prevent hair loss during chemotherapy.
Locations (1)
Jessa Hospital
Hasselt, Limburg, Belgium